Skip to content

News
Events
Research
Resources
About
Submit

The National MPS Society and COVID-19

Posted on May 11, 2020

The National MPS Society USA has posted recommendations for patients and families concerned about COVID-19.

Posted in News | Tagged COVID-19, COVID-19 Recommendations, MPS Society

Post navigation

10 present and former LDN members to present latest research at WORLDSymposium

FSIG provides online application to assist in patient care during COVID-19 crisis

Recent Posts

Gaucher patients in Spain turn to home-based infusions to avoid COVID-19 exposure
National Gaucher Foundation shares COVID-19 tips, precautions, and more …
NTSAD COVID-19 announcement
Recent research reviews the impact of COVID-19 on lysosomal disease patients
FSIG provides online application to assist in patient care during COVID-19 crisis

Contact Information

Lysosomal Disease Network
420 Delaware Street SE
MMC 446
Minneapolis, MN 55455
info@nulllysosomaldiseasenetwork.org

Chester B. Whitley, PhD, MD
Principal Investigator,
Lysosomal Disease Network
Professor, Dept. of Pediatrics
University of Minnesota,
Twin Cities

David CC Erickson
Informatics Director,
Webmaster
Lysosomal Disease Network

James C. Cloyd, PharmD
Co-Principal Investigator,
Lysosomal Disease Network

Brenda Diethelm-Okita, MPA
Program Manager,
Lysosomal Disease Network

Additional Info

Official List of Lysosomal Diseases
Submit Content to LDN
Sign up for PubMed Updates
Apply for LDN Fellowship
Submit RFA for Pilot Project
Lysosomal Disease Network Fellows
Contact LDN

Recent Posts

Gaucher patients in Spain turn to home-based infusions to avoid COVID-19 exposure
National Gaucher Foundation shares COVID-19 tips, precautions, and more …
NTSAD COVID-19 announcement
Recent research reviews the impact of COVID-19 on lysosomal disease patients
FSIG provides online application to assist in patient care during COVID-19 crisis

The Lysosomal Disease Network (U54NS065768) is a part of the National Institutes of Health (NIH) Rare Diseases Clinical Research Network (RDCRN), supported through collaboration between the NIH Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS), the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

© 2020 Lysosomal Disease Network